Advances in Biomedical Engineering, Part A, Volume 402 provides a comprehensive overview of the latest developments, innovations, and research in the rapidly evolving field of biomedical engineering. This book covers a broad spectrum of topics, including medical imaging, biomaterials, tissue engineering, biomechanics, bioinstrumentation, and healthcare technologies. Specific chapters include Advances in biomedical engineering, Recent advances in nanomedicine as drug delivery systems, Advances in Nano biomaterials for Biomedical Engineering, Neurodiagnostic: Advances in diagnostic tools, Advances in Ferroptosis Research and Application, Bioink-based 3D Bioprinting: Paving the Path for Regenerative Medicine, and MRI Acute/Sub-Acute Ischemic Stroke Segmentation with Deep Learning: A Comprehensive Review.
- Explores the latest developments and trends across all major areas of biomedical engineering, including biomaterials, medical imaging, biomechanics, bioinformatics, and tissue engineering
- Presents state-of-the-art research, innovative methodologies, and emerging technologies that are shaping the future of healthcare and medical devices
- Integrates knowledge from engineering, biology, medicine, and computer science to provide a holistic understanding of biomedical challenges and solutions
Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.
Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:
OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
Sheila Spada is at Weill Cornell Medical College, NY, USA
Dr. Chu is currently the Director of the Center for Biomedicine and Community Health and the Dean of the Faculty of Applied Sciences, International School, Vietnam National University (VNU), Hanoi, Vietnam. He is also a visiting Professor at the Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan. He achieved a Doctor of Veterinary Medicine degree from Vietnam in 2006, a Master of Biological Science from in South Korea in 2011. From 2011 to 2015, he participated in an EU-funded program in. Poland for the Ph.D. program in diet-induced obesity, genetic effects, and epigenetic regulations of lipid metabolism and obesity, and got a PhD in medicine (medical Biology). Dr. Chu continued his journey as a postdoc and researcher in molecumar biomoedicine under a Marie Curie Postdoctoral Research Fellowship at the Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo (Norway) from 2015 to 2018. Up to now, he has over 190 WoS/Scopus publications in biomedicne and community health with more than 21000 citations (Scopus, updated by 5/2023). He has also reviewed over 40 qualified scientific journals with more than 300 manuscripts and handed over 250 manuscripts as an editor for several WoS/Scopus journals such as Bioengineered and PLOS ONE. In 2022, the Stanford List recognized him as the Top 2% Scientists in the World.
